Within a low-amino-acid diet, methionine had a Goldilocks range in aged mice: too little increased frailty, while a moderate amount preserved lean mass and improved metabolism.
Amino-acid restriction can improve metabolic health in animals, but old age makes the tradeoff sharper: restrict too much, and the diet may accelerate muscle loss and frailty. In these mice, methionine determined where restriction stopped helping and started harming.
Researchers fed genetically diverse male and female mice, beginning at 20 months of age, several diets that included low-amino-acid formulations with different methionine levels.
Enjoying this research? Get deeper insights like this delivered every other week.
Every other week our Premium Members receive deep dives like this alongside Rhonda's commentary and 8+ other hand-picked papers.
The moderate-methionine, low-amino-acid diet produced the broadest healthspan profile:
- It reduced fat mass and frailty, preserved lean mass, and improved glucose tolerance, insulin tolerance, and weight-adjusted grip strength.
- It lowered IGF-1 while raising growth hormone, GLP-1, and FGF21; without FGF21, much of the fat loss and improvement in insulin sensitivity disappeared. This places FGF21 near the center of the diet's metabolic effect.
- It did not significantly extend lifespan compared with the healthy control diet.
A separate analysis of adult dietary patterns found roughly twice the prevalence of type 2 diabetes among people with the highest versus lowest animal-protein intake. The estimate cannot isolate methionine from its food sources, and the mouse intervention does not support adding methionine to an ordinary or high-protein human diet.
Rather, the experiment reveals a narrow balance within amino-acid restriction: too little methionine increased frailty, whereas too much erased metabolic benefits. Methionine's effects appear to depend on the surrounding protein context and an intact FGF21 response, rather than being inherently beneficial or harmful. In a recent Q&A, Dr. Rhonda Patrick discussed why fasting-mimicking diets deliberately restrict protein while emphasizing strategies to preserve muscle.
Study coauthor Valter Longo has equity in L-Nutra, and several authors and USC hold or have licensed patents related to the dietary methods.
Press Release: Low-protein, amino acid-supplemented "longevity diet" linked to longer healthy lifespan, lower frailty risk, better metabolic health
Study: Methionine-supplemented longevity diet increases growth hormone, GLP-1, and FGF21; reduces frailty; and promotes healthspan